US03890D1081 - Common Stock
Aravive Inc
NASDAQ:ARAV (1/26/2024, 7:02:10 PM)
After market: 0.042 +0 (+4.74%)0.0401
-0.01 (-13.39%)
Aravive, Inc. operates as a clinical stage biotechnology company, which engages in the development of transformative treatments designed to halt the progression of life threatening disease, including cancer and fibrosis. The company is headquartered in Houston, Texas and currently employs 23 full-time employees. The company went IPO on 2014-03-20. The firm is focused on developing treatments designed to halt the progression of life-threatening diseases, including cancer and fibrosis. The firm's lead product candidate, Batiraxcept, is an ultra-high affinity decoy protein that binds to GAS6, the sole ligand that activates AXL, thereby inhibiting metastasis and tumor growth, and restoring sensitivity to anti-cancer agents. Batiraxcept has been granted Fast Track Designation by the United States Food and Drug Administration (FDA) for both clear cell renal cell carcinoma and platinum-resistant ovarian cancer and Orphan Drug Designation by the European Commission in platinum-resistant recurrent ovarian cancer. Batiraxcept is in an active registrational Phase III trial in platinum-resistant ovarian cancer (NCT04729608), a Phase Ib/II trial in clear cell renal cell carcinoma (NCT04300140), and a Phase Ib/II trial in pancreatic adenocarcinoma (NCT04983407).
Aravive Inc
River Oaks Tower, 3730 Kirby Drive, Suite 1200
Houston TEXAS 77098
P: 19363551910
CEO: Gail McIntyre
Employees: 23
Website: https://aravive.com/
We're starting the final day of trading this week with a look at the biggest pre-market stock movers for Friday morning!
Shell layoffs are coming for hundreds of the company's employees with the cuts starting with its Low Carbon Solutions division.
Nuvve stock is sliding lower on Thursday after the company announced a one-for-40 reverse split for shares of NVVE tomorrow.
Aravive stock is falling hard on Thursday after the company announced plans to voluntarily delist shares of ARAV from the Nasdaq!
Pre-market stock movers are a hot topic this morning as we check out all of the winners and losers worth keeping tabs on for Thursday!
Aravive (ARAV) announces plans to voluntarily delist from Nasdaq and transfer its assets for creditors, leading to its dissolution and liquidation.
Here you can normally see the latest stock twits on ARAV, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.
Example Twits: